Understanding the Interplay Between Sudomotor Dysfunction, Nerve Damage, and Gland Morphology in Type 2 Diabetes
Diabetic neuropathy (DN) is one of the most debilitating complications of type 2 diabetes mellitus, affecting both large and small nerve fibres. Among the earliest signs of neuropathy is sudomotor dysfunction — the impaired ability to sweat due to damage in the autonomic nervous system.
This subtle but important dysfunction contributes to foot skin dryness and increased risk of ulceration. Ishibashi et al.’s study explores how sudomotor impairment correlates with both the structural state of sweat gland ducts and the degeneration of small nerve fibres in the cornea, using cutting-edge confocal microscopy techniques.
Background
Sudomotor function is governed by small unmyelinated C fibres, which are among the first to deteriorate in diabetic neuropathy. Loss of sweat production, particularly on the feet, is a well-recognized precursor to foot ulcers. Traditionally, assessing this function has required invasive or expensive techniques. However, non-invasive tools such as corneal confocal microscopy (CM) and quantitative assessment of sweat gland duct morphology have opened new frontiers in identifying neuropathic changes earlier and more precisely.
Prior studies have shown that the Indicator Plaster Method (IPM) test — which measures the time it takes for a colour-changing patch on the foot to react to sweat — is a reliable proxy for sudomotor dysfunction. However, direct correlation between this functional impairment and visible structural changes in sweat glands and corneal nerve fibres in type 2 diabetes had not been thoroughly studied. This investigation bridges that gap.
Methods
The study enrolled 78 patients with type 2 diabetes and 28 age-matched healthy controls. Diabetic patients were stratified into five stages of neuropathy severity using criteria from the Diabetic Neuropathy Study Group in Japan, ranging from no neuropathy (Stage I) to severe clinical involvement (Stage IV+V).
Sudomotor function was assessed using the IPM test on the soles of the feet, quantifying the time to complete colour change (CCC) from blue to pink.
Corneal nerve fibre morphology — including density, length, branching, tortuosity, and beading — was measured using corneal confocal microscopy.
Sweat gland ducts were visualized on the finger pad using CM, with their cross-sectional area (CSA) calculated as a marker of structural integrity.
Other clinical parameters (e.g. blood glucose, lipid profiles, nerve conduction studies, thermal perception thresholds, uric acid levels) were recorded to evaluate correlations and control for confounding factors.
Key Findings
1. Sudomotor Dysfunction Increases with Neuropathy Severity
The time required for the IPM to change colour increased progressively with worsening diabetic neuropathy. While patients without neuropathy had IPM responses comparable to controls, those in more advanced stages showed significant delays, reflecting impaired sweat production.
2. Sweat Gland Ducts Are Structurally Altered Even Before Overt Neuropathy
Even patients with diabetes who did not yet meet criteria for neuropathy had significantly smaller sweat gland ducts than healthy controls. The CSA of these ducts declined further in more advanced neuropathy, suggesting that structural gland changes may precede or accompany early nerve damage.
3. Corneal Nerve Fibre Pathology Correlates with Sudomotor Function
Corneal nerve fibre density, length, and branching were all inversely correlated with the time to CCC in the IPM test. In other words, greater nerve fibre damage was associated with worse sudomotor function. These relationships remained significant even after adjusting for age, BMI, and other variables.
4. Sweat Gland Duct Size Mirrors Nerve Health
The CSA of sweat gland ducts was positively associated with corneal nerve branch parameters, indicating that smaller ducts were linked to greater nerve fibre loss. Interestingly, duct size also correlated with serum triglyceride and uric acid levels, although the physiological significance of this remains unclear.
5. Independent Predictors Identified
Regression analyses confirmed that both the severity of diabetic neuropathy and corneal nerve branch loss were independent predictors of sudomotor dysfunction. Conversely, triglycerides, uric acid, and corneal nerve branching were the main predictors of sweat gland duct size.
Conclusion
This study provides compelling evidence that sudomotor dysfunction in type 2 diabetes is not an isolated phenomenon, but rather intimately linked with both nerve fibre degeneration and sweat gland duct atrophy. Sudomotor performance declines in tandem with diabetic neuropathy severity and correlates strongly with structural nerve loss visible in the cornea. Similarly, shrinking sweat gland ducts — measurable non-invasively in the fingers — may reflect broader autonomic degeneration.
These findings emphasize the importance of early and integrated assessment of neuropathy, beyond just symptom questionnaires or large fibre tests like vibration perception. Using tools like the IPM test, corneal confocal microscopy, and sweat duct imaging could allow for earlier detection and more precise stratification of nerve damage in diabetes, potentially helping to prevent irreversible complications such as foot ulceration and limb amputation.
Although the study is cross-sectional and limited to surrogate measures in different anatomical locations (feet vs. fingers), its insights strongly support a structure–function relationship in diabetic sudomotor and nerve pathology. Further longitudinal studies may help clarify causality and guide interventions.